Skip to content
ClinCalc Pro
Menu
Synthetic Pyrethroid (Antiparasitic) Pregnancy: §4.6: there are only limited data on use in pregnant women, so treatment should be considered during pregnancy only if clearly needed; the amount of permethrin absorbed systemically following whole-body application is extremely low and any risk to the foetus is suggested to be minimal. Breast-feeding: it is not known whether permethrin is excreted in human breast milk; consideration should be given to withholding treatment during nursing or temporarily discontinuing nursing.

Permethrin

Brand names: Lyclear (5% cream)

Permethrin is a topical insecticide used for scabies and head lice.

Auto-extracted from the source labelling — not yet independently clinician-verified. These values were distilled from the UK SPC (or the US label where noted) but have not had a clinician sign-off. Confirm against the current SmPC before prescribing.

Adult dose

Dose: Scabies — adults and adolescents over 12 years: apply up to 30 g of PERMETHRIN 5% w/w CREAM (corresponding to one 30 g tube) as a thin layer to the skin; repeat the application 7 to 14 days after the first treatment.
Route: Cutaneous (topical) use only — permethrin 5% w/w cream. The medicinal product must not be swallowed.
Frequency: One application, repeated 7 to 14 days after the first treatment; wash the whole body thoroughly 8 to 12 hours after each application (crab lice: leave on for 24 hours — see notes)
Max: Up to 30 g of permethrin 5% w/w cream (one 30 g tube) per application in adults and adolescents over 12 years
STRENGTH IS PART OF THE DOSE: the UK SPC used here is Permethrin 5% w/w Cream (the scabies/crab lice strength). The openFDA record in the same bundle is a 1% permethrin creme rinse for head lice ('good sense lice killing creme rinse', L. Perrigo) — a different strength, product and indication; its instructions are NOT reproduced here and must not be applied to this entry. APPLICATION FOR SCABIES: carefully apply a thin layer of cream; adults, adolescents and children over 2 years should apply uniformly to the WHOLE BODY including the neck, palms of the hands and soles of the feet; the head and face can be spared unless scabies efflorescences are present there; treat the areas between fingers and toes (including under finger- and toe-nails), wrists, elbows, armpits, external genitalia and buttocks especially carefully. Apply to clean, dry, cool skin — if a warm bath has been taken, allow the skin to cool first. It is a vanishing cream: rubbed gently into the skin it disappears, so there is no need to keep applying until it remains visible. Wash the whole body thoroughly 8 to 12 hours after treatment. Approximately 90% of individuals are cured with a single application; if necessary a second application may be given not less than 7 days after the initial application, if there are no signs of the original lesions healing or if new lesions are present. ELDERLY (over 65 years): use the cream in the same way as adults, BUT the face, ears and scalp should also be treated, taking care to avoid applying cream to skin around the eyes. CRAB LICE — adults over 18 years: apply up to 30 g of the 5% cream to cover the pubic region, peri-anal area, inner thighs down to the knees and any hair growing up from the pubic area to the chest/stomach; leave on the skin for 24 hours, then wash the treated areas thoroughly. Check any facial hair (beards, moustaches) and eyelashes for live lice and eggs; cream may be applied to facial hair carefully avoiding the eyes, but must NOT be applied to the eyelashes (it can cause moderate eye irritation) — remove lice or eggs from eyelashes carefully with tweezers. PAEDIATRIC (numbers deliberately withheld here): the SPC gives reduced cream quantities by age band for children aged 6 to 12 years and 2 months to 5 years, repeated 7 to 14 days after the first treatment; safety and efficacy in children under 2 months have not been established (no data), and only limited experience is available in children aged 2 to 23 months, in whom treatment must be given only under close medical supervision. Children under 2 years should have the cream applied to the whole body including palms, soles, neck, face, ears and scalp, sparing skin around the mouth (the cream could be licked off) and the eyes; children should be kept from licking cream off their hands and may need gloves. Verify all paediatric dosing against a children's formulary. SAFETY: avoid contact with the eyes, mucous membranes and open wounds; nursing staff who routinely apply the cream may wish to wear gloves. The cream's paraffin excipients can reduce the reliability of latex products (condoms, diaphragms) and make fabric that has been in contact with the product burn more easily — instruct patients not to smoke or go near naked flames.

Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.

Contraindications

  • Hypersensitivity to the active substance permethrin, to other substances of the pyrethrin group, or to any of the excipients — in such cases treatment should be switched to a chemically different antiscabies agent (§4.3)

Side effects

  • Common — paraesthesia and skin burning sensation
  • Common — pruritus, erythematous rash, dry skin
  • Rare — headache; nausea; excoriation, folliculitis, skin hypopigmentation
  • Very rare — contact dermatitis, urticaria
  • Dyspnoea in sensitive/allergic patients; in scabies, itching may persist for up to 4 weeks post-treatment (allergic reaction to dead mites, not necessarily treatment failure)

Interactions

  • §4.5: 'No interactions are known.'
  • Corticosteroids — treatment of eczematous-like reactions with corticosteroids should be withheld prior to treatment with permethrin 5% w/w cream, as there is a risk of exacerbating the scabies infestation by reducing the immune response to the mite (§4.5)

Clinical monograph

How it works

It is a synthetic pyrethroid that disrupts sodium channel function in the parasite's nerve membranes, causing paralysis and death of mites and lice.

Prescribing in practice

  • For scabies, treat all close physical and household contacts at the same time, whether or not they have symptoms, to prevent reinfestation.
  • For scabies, apply to the whole body including the neck, face where affected in older adults, and under the fingernails and toenails, washing off after the period specified in the SPC and usually repeating the application.
  • Persistent itching can continue for several weeks after successful treatment and does not by itself indicate failure or the need to re-treat.

Monitoring

No laboratory monitoring is required; review if itching is worsening rather than gradually settling, or if new burrows or lesions appear after treatment, which may suggest reinfestation or treatment failure.

Counselling the patient

  • Treat all close contacts and household members on the same day, even those without symptoms.
  • For scabies, apply to the whole body as directed, including under the nails, and reapply after laundering hands if they are washed during the treatment period.
  • Itching may last for some weeks after the mites are cleared and usually settles; seek review if it is getting worse or new spots appear.

Evidence & guidelines

First-line topical treatment for scabies (NICE CKS scabies).

Reference: NICE NG225; PHE Scabies Guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.